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The authors describe 12 cases with this condition, after exclusion 
of other aetiologies (Salmonelfa, Mycobacteriurn tuberculosis or Brucella 
spp). From the total of patients admitted to the Unit during the last 
four years (1995-1998), 7 were males (58.3%) and 5 were females 
(41.6%). The majority had spontaneous discitis (83.3%) and 2 patients 
had undergone surgical treatment of the herniated disk, prior to the 
development of discitis. Lower back pain was the major symptom and 
fever was present in 66.6%. In 4 cases (33.3%) the identification was 
made after aspiration or drainage and in 50%, positive blood cultures 
led to the identification. Gram-positive organisms were found in 
41.6% (St .  aureus-2, S I .  epidermidis-2 and St. chromogenes-1); 
Gram-negative rods were cultured in 33.3% (E.coli) and an anaerobe 
agent (Prevotefla buccalis) was identified in 1 case. The pathogens in 
the remaining cases (16.6%) were not identified. Two of these were 
alcoholic (16.6%) and two were diabetic. Leukocitosis was present in 
41.6% of the patients and ESR was high in 100% of the patients. The 
sites at which spondylodiscitis were reported were lumbar (83.3% of 
the cases) and dorsal (16.6%). All of the patients underwent antibio- 
therapy for at least 4-6 weeks. One patient died due to infectious 
complications after being submitted to vertebral surgery. 
In conclusion, the authors draw attention to the importance of 
lumbalgia, when occurring with a long and progressive course, as a 
symptom of spondylodiscitis. 
Lemierre’s Syndrom-a case report 
UEibell, G.Feierl’, M. Darokz, E. Daghofer’, A. Grisold’, 
E.Marth’ ‘Institute of Hygiene, University of Graz, ‘Institute of 
Forensic Medicine, University of Graz, Austria 
Objectives: Lemierre‘s Syndrom is described as a post-tonsillitis 
septicaemia caused by Fusobactrrium necrophorum with possible inva- 
sion of the lungs, osteomyelitis, endocarditis, meningitis and impaired 
liver function. Mostly young, previously healthy people are affected. 
Letality is about lo%, even with adequate antibiotic treatment. 
Case report: The 18 year old patient consulted his general prac- 
titioner because of a sore throat, pain in the left ear with supperative 
secretion and fever up to 39‘ C for the past three days. The physi- 
cian diagnosed tonsillitis and prescribed a macrolid antibiotic. During 
the next day the patient developed a severe headache and was admit- 
ted to the neurological clinic in the evening. Diagnosis was menin- 
gitis purulenta, mastoiditis and otitis media of the left ear. Antibiotic 
treatment with standacillin, penicillin G and gentamicin was started. 
Early on the next day the patient was transferred to the otolaryngol- 
ogy hospital for an emergency mastoidectomy. A dramatic deterio- 
ration of the patient’s condition followed with diffuse cerebral 
oedema resulting in irreversibly elevated intracranial pressure.The 
patient died on the next day. 
Results: We were able to detect Fusobacterium necrophomm in CFS 
and anaerobic blood cultures. It was also possible to culture 
Fusobacterium necrophorum from meningeal swabs post mortem but not 
from the tympanic cavity. The autopsy revealed meningitis purulenta 
and massive cerebral oedema. A suspected otogenic source of the 
meningitis could not be verified. 
Conclusion: Although Lemierre’s syndrom is a very rare compli- 
cation following tonsillitis it should be considered. If the physician 
had treated the patient’s tonsillitis with penicillin, the young man’s 
recovery would have been hypothetical, but probable. 
[ml Ceftriaxone (Rocephin) in the treatment of 
severe infections 
I .  Rebedea. G. Coltan, A. Dragusanu. Ir. Rebedea, C. Marin, 
Cofentitia Hospital .f Infectious Diseases, Bucharest, Romania 
Objectives: To establish the efficacy of ceftriaxone (Rocephin) clas- 
sified as the third generation cephalosporin in the treatment of severe 
infections. 
Methods: A clinical trial was performed from 1997-1998 on 125 
severe infections including: 73 cases of meningitis (58.4%), 35 lower 
respiratory tract infections (28%), 13 septicaemia (10.4%), and 4 
endocarditis (3.2%). 
Results: Only Rocephin, 1-2 g tds or once daily, was adminis- 
tered at the beginning in 41.6% of the cases (44 bacterial meningi- 
tis, 8 pneumonia) for 7-14 days. In 49.6% cases of septicaemia and 
endocardins, Rocephin was frequently associated with aminoglyco- 
sides or quinolones. Towards the end of the cure the doses were 
reduced to l g  intravenously per day. 
Conclusions: For most severe infections Cefiriaxone (Kocephin) 
is the most potent third-generation cephalosporin (excellent bacte- 
ricidal activity and penetration into the CSF). Rocephm was admin- 
istered frequently in monotherapy and sometimes in association 
(quinolones and aminoglycosides). 113 patients (90.4%) of 125 
treated with Rocephin recovered con~pletely clinically and bacterio- 
logically. Many severe infections can be treated with one daily dose 
of Rocephin. No secondary reactions were observed. The cost of 
therapy is compensated for by efficacy, short hospitalization, facili- 
tating of administration and improvement in the quality of life. 
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Ip10981 Association of Chlamydia pneumoniae (Cpn) 
IgG and IgA antibodies with ischaemic heart 
disease (IHD) 
V. Petrocheilou, M. Alexandrou, J. Germanides, M. Xenoyianni, 
and J. Darsinos. Dept. of Clinical Therapeutics, University o f  Athens, 
Medical School, Bacteriology Dept. Afexandra Hospital, Athens, Greece 
Chlamydia pneumomae is a recently recognized species; it has a vari- 
ety of clinical presentations and there is evidence indicating associa- 
tion with ischaemic heart disease. 
Objectives: In order to evaluate this possibility the antibody 
response to Cpn in Greek patients was studied. 
M e t h o d  Cpn specific IgG, IgA and IgM antibody titers of 132 
IHD patients (aged 36-70y) and 43 sex and age matched controls, 
were measured by using micro-immunofluorescence test (TW-I83 
Cpn strain, B105 GmbH, Postfach 1640). Titers 40 IgG were consid- 
ered positive for chronic Cpn infection. 
Results: IgM antibodies were negative in all sera tested. Both IgG 
and IgA antibodies were found significantly different between the two 
groups. 
I IHD Datients I Controls 1 
Conclusions: These findings indicate a high association of chronic 
Cpn infection with IHD patients. 
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m1 Do Chlamydia pneumoniae or CMV infections 
favor the acute myocardial infarction? 
€? Martinez Martinez', J. Berriiejo', W. Martin-', R. Ortiz de 
Lejarazu', F. del Pozo', JM(a). Eiros', E Fernandez-AviEs'. 
'hficrobiolugy Service, 'Cardiolo'q y Service, .' Statistical 
Department, Ckirvrsify Hospital, Ihlladolid, Spain 
Objetives: To evaluate the pcissible relationship between Chlamydia 
pneunioniae or CMV infection; and acute myocardial infarction. 
Methods: A total of 140 individuals participated in the study, most 
of them males (79.2%); 40 patients with stable coronary illness (SCI) 
(64210 years), 60 patients with acute coronary syndromes (ACS) 
(62?13 years) and 40 blood donors as control group (CG) (5325 
years) 
Serum samples were tested using a technique associates a final 
automated, fluorescence reading with an indirect imniunoenzyniatic 
inethod (VIDAS CMV, bioM6rieux France) and microimmunofluo- 
rescence (Strain 2073, ATCC 1356 VR) (Vircell S.L.) for Chll 'and 
Chlamydia nenmoniae respectively. 
ACS samples were taken during the acute phase (60 samples for 
IgM and IgG1) iand a month (48 samples for IgG2, 5 losses during 
the study and 7 deceaseds), while in the rest of the participants only 
sample was obtained (80 samples for IgG). A sample was considered 
positive for Chi l 'when it presented IgMaO. 90 Ua/ml or IgG2h 
Ua/nd. The sera were tiara in two-fold dilutions starting from 1/12 
(positive titre 31/12)  and 1/64 for IgM and IgG respectively of 
Chlani ydia pneumoniae. 
Results: AD sainples were negative for IgM. The IgG titres 
11 /513  (recent infection) represented 9% of the cases (4 CG, 6 SCI 
and 2 ACSI). Only 14.9% ofthe samples was negative for CMV IgG 
(<6  Ua/ml) and 30.9% Chlamydia pneumoriiar IgG titres was 3 1/64. 
Seroconversions were not detected. 
Conc1usions:The results do not seem to confirm a relationship 
between the acute coronary syndrome and an infection for Chf170r 
Claniydia pneumoniae. 
Activity of antibiotics in eliminating 
Chlamydia pneumoniae cardiovascular 
strains from cell types involved in the 
pathogenesis of arteriosclerosis 
J. Gieffers, W. Solbach, M. Maass. Institure ofhfedical Aficrobiology 
and Hygiene, Afedical linitwsity of Lttbeck, Ltibeck, Gcrmawy 
The detection of chlamydia1 citructures in diseased vessels and the 
isolation of viable chlamydiae from atheromatous plaques led to pilot 
studiec of antibacterial treatm'tnt in patients with coronary artery 
disease. As cardiovascular isolates of C. pneunioniae have not been 
available until very recently, little knowledge exists about their 
susceptibility characteristics. In this study, the activity of ofloxacin. 
ciprof-loxacin, doxycycline, erythromycin, roxithroniycin, 
azithromycin and rifampin in (eliminating two cardiovascular strains 
from cell types involved in the pathogenesis of arteriosclerosis was 
investigated. Priinary and immortalized epithelial, endothelial, 
smooth muscle, and nionocytic cells were studied. Twofold dilutions 
of each antibiotic were added to the cells during infection with C. 
pweumoniae elementary bodies, liifection was detected by fluore+ 
cence staining, and the miniinal inhibitory concentration (MIC) was 
determined for every antibiotic and cell type. All antibiotics tested 
eliminated C. pneumoniae in mdothelial and smooth muscle cells 
with MlCs similar to those found in epithelial cells (HEp-2). In vitro 
macrolides were more effective than quinolones and doxycycline; 
rifainpin was the most effective antibiotic. All antibiotics failed to 
prevent chlaniydial infection i n  monocytec. Chlamydia1 replication 
in an early phase was noticed, but evidence of longer-term survival 
could not be provided: subcultivation on HEp-2 cells failed, regard- 
less of ailtibiotic treatment of the monocytec. Further studies on this 
phenomenon are underway However, regarding permanent cells 
of the arteriosclerotic vessel walls, the data of this study indicate 
that endovascular chlamydiae may be eradicated by variouc antibi- 
otics. 
(p11011 High Chlamydia pneumoniae seropositivity in 
coronary artery disease 
G. Revathi, S.V. Madhu, G. Shatapati. A. Arvind. Keriyatta .Yatioird 
Hospital, Nairobi, Kenya; I K X f S B  Ho.rpitul, Delhi, lridin 
Objectives: To discover an association. if any, between C. prieunio- 
riiar exposure and coronary artery disease in our hocpital, since \ome 
recent studies in Europe and the USA have linked these two ~iitities. 
Methods: 102 patients, 75 male and 27 female, with confirined 
CAD were studied. They were diagnosed by clinical tests, ECG, 
blood chemistry and serum enzymes. Those with complicating respi- 
ratory conditions, metabolic diseases and acute febrile illnesses were 
excluded. A detailed history and all risk factors were recorded on 
predesigned forms. C. pneurnoniae IgG was detected in the \eruni by 
niicroiiiiinunofluorescence technique. A titer of 1 :I6 indicated a 
poritive result. Titers below 128 were taken as low titers, whilc titers 
above 178 were taken as high titers. Data from 100 healthy blood 
bank donors were used as controls. 
Results: ( I )  Sera from 52 control subjects tcstrd positive h i -  C. 
pncunioniae IgG; only three had high titers. (2) 99 sera from the study 
group tested positive, out of which 57 had high titers. ( 3 )  
Distribution of other risk factors was equal among thotc with high- 
and low-titer antibodies. 
Conclusions: There appears to be .I casual link between expo- 
sure to C. pricumuniae infection and CAD in our patients. This neces- 
sitates specific diagnosis and chemotherapy of these infections. 
Detection of serum antibodies against 
Chlamydia pneumoniae by ELISA 
1. Kondova-Topuzovska, K. Karovski, M. Filipce, L.J. Ilieva, J. 
Damchevska. Medical Facrrlty, Clinicfvr Irlfrrfivc Disaasc, Skopjr, 
Marcdonin 
Chlamydia pneumoniae seems to be an iniportant pathogen, responsi- 
ble for 10-20'!6 of community-acquired pneunionia in adole\cent and 
adults. 
Objectives: To evaluate the diagnostic value of detection of serum 
antibody by ELISA for Chlamydia pneumoriiap in 56 adult hospitalized 
patients with community-acquired pneumonia. 
Methods: Serun-specific IgM, IgG and IgA antihodie\ tu 
Chlamydia pnentnoniae were determined in Jcutc and convalescent 
serum by ELISA Sero CP (Savyon Diagnostics) based on purified 
elementary bodies of Chlainydia pneumotiiar antigens. 
Results: Of 56 sera from adult patients hospitdlized with pneu- 
monia, Chlamydia pncirmoniae IgM was positive in 4 (7.14'%1) patients; 
IgG and IgA were positive in 6 (lfI.71''4~), with significant increascs 
in 1 (1.79%) convalescent sample; IgG alone was detected in 13 
(23.21%)). 
Conclusions: We can conclude that acute Chlnriiydiu pneuinorirnc 
infection was present in 5 (8.93%) ca\es of commuiiity-acquired 
pneumonia in hospitalized adult patient\. No single w u i n  can be me 
for final diagnosis of Chlamydia pwerrmo&w infection, so this offers 
only a retrospective diagnosis, which makes it difficult to manage 
these patients prospectively. 
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Im] The seroprevalences of anti-Chlamydia 
pneumoniae IgG antibodies in Turkish 
patients undergoing coronary artery bypass 
engraftment 
K. Midilli', H.  Arbatli', E. Demirsoy', S. Ergin', B. Ulgen', B. 
Sonniez2, K. Altas'. 'Microbiology Department, Cerrahpasa School o f  
Medin'tze, 'Cardiovascular S u p ~ y  &partmeat, Fiorence Nkhtinxale 
Hospital, Istanbul, Turkey 
Objectives: There is accumulating evidence indicating a link 
between chronic C. pneumoniae infection and atherosclerosis and 
coronary heart disease (CHD). We aimed to determine the sero- 
prevalences of anti-C. pneumoniae IgG antibodies in CHD patients 
undergoing coronary bypass engraftment and in healthy controls. 
Patients and methods: 99 CHD patients (80 males and 19 
females; mean age 58.7528.97 years) and 50 healthy controls (36 
males and 14 females; mean age 52.52k9.74 years) were included in 
the study. Anti-C. pneumoniae 1gG antibodies were determined by 
microimmunofluorescence assay (Euroimmun, Germany). Sera were 
tested at three dilutions, 1:16, 1:32 and 1:64. 
Results: The results are presented in the tables below: 
>1:32 I >1:64 
Conclusions: The differences between patient and control groups 
regarding the seroprevalences of anti-C, pneumoniae IgG antibodies at 
ddutions of 1:16 and 1:32 were statistically insignificant (p values 
0.077 and 0.24, respectively}, but significant at a dilution of 1:64 
(p<0.0013, OR=5.14). Our results 3re consistent with other reports 
indicating a link between CHD and anti-C. prreumoniae antibodies of 
higher titers, e.g. 1:32 and 154. 
m1 Rapid diagnosis of Bartonella henselae 
infection by polymerase chain reaction and 
microwell hybridization assay 
R. Del Prete, V. Basile, A. Mosca, L. Fumarola, D. Fumarola, 
G.Miragliotta. Section of Microbiology and Immunolofl, Department .f 
Clinical Medicine, Immunology and lnjctious Diseases, University o f  
Bari, Italy 
Objectives: To diagnose B. hemehe infection in the blood of a cat 
scratch disease (CSD) patient by PCR and non-isotopic method of 
amplicon detection. 
Patients and methods: In order to recover B. henselae DNA, 200 
BL of peripheral whole blood from an immunocompetent 7-year-old 
boy without systemic manifestations of disseminated CSD and with 
serologic evidence of B. henselae infection (IgG, IFA, FULLER 
Laboratories, Fullerton, CA, USA; dxstributed in Italy by ARNIKA, 
Milano, Italy) was processed by InstaGene Whole Blood Kit (BlO- 
RAD Laboratories, Heretics, CA, USA), following the manufac- 
turer's instructions. A single-step PCR assay with the primer pair 
CATl/CAT2 designed to specifically target the htrA heat shock 
protein-like gene of the B. henselae genome was performed. The 
expected 418-bp DNA fragment was detected by 2% ethidium 
bromide-stained agarose gel in a precast electrophoresis system (E- 
GEL; Invitrogen BV, NV Leek, The Netherlands). The amplicons 
were identified by a colorimetric procedure (GEN-ETI-K DEIA, 
DiaSorin, Saluggia, Italy) based on the hybridization of the denatured 
DNA with a 5 -biotinylated inter-primer specific oligonucleotide 
probe (BHl), captured in a niicrotiter plate coated with streptavidin. 
The hybrids were detected by an anti-monoclonal antibody and 
revealed by an ELISA-like technology In order to exclude possible 
contamination among the samples, strict precautions were taken and 
PCR-positive and PCR-negative controls were included. 
Results: The patient had a bloodstream infection of B. henselae. 
The amount of PCR products detected by this assay was 10 times 
less than that detected by agarose gel electrophoresis. 
Conclusions: On the basis of the reported expanding clinical 
manifestations of CSD, it seemed logical to search for B. hemelae in 
patient's blood. Our findings suggest thas PCR-DEIA, a specific and 
sensitive technique, may be suitable f i r  the rapid diagnosis of B. heme- 
lae infection in CSD patients. 
m] Vasculitis and neuropathy due to infection 
with Bartonella henselae 
B. Stocheyer, C. Schorner, J.R. Kalden, T. Harrer. University of 
Erlangen-Nurembetg, Erlagen, Germany 
Introduction: Bartonella henselae is known as cause of cat scratch 
disease and bacillary angiomatosis. Here, we describe an immuno- 
competent patient suffering from chronic vasculitis and polyneu- 
ropathy due to infection with Barfonella henselae. 
Case report: The 40-year-old presented with a plantar vasculitic 
ulcer on the big toe of the right foot and with a polyneuropathy. The 
symptoms had suddenly emerged 7 years before and had been refrac- 
tory to treatment with high-dose steroids. Serologic analpis revealed 
a strong elevation of antibodies to Bartonella henselae (IFT 1:1024) and 
a borderline titer to Bartonella quintana (IFT 1:128). Biopsy of the 
ulcer revealed excoriating hyperkeratosis with proliferation of blood 
vessels, but no bacteria in the silver stain. Under antibiotic therapy 
with erythromycin, the ulcer healed, the polyneuropathy improved 
and the antibody titer to Barfonella henselae dropped to 1:256 in the 
IFT. The patient could not remember any contacts with cats and 
none of his family was infected with Bartonella. 
Conclusions: Infection with Bartonella henselae should he consid- 
ered in cases of chronic unclassified vasculitis and polyneuropathic 
syndromes, even without known exposure to cats. 
[p11061 Hemodialysis catheter infections 
M.R. Altiparmak', K. Gungor', R. Ozturk*, E Tab&*, R. 
Ozgenc3, R. Ataman. 'Nephrology Section, Internal Medicine 
Department, Isranbul University, 'Clinical Bacteriology and rnfectiotcs 
Diseases Department, Cerrahpasa Medical Faculty, 'Clinical Microbiology 
and Microbiology Department, Istanbul University, Istanbul, Turkey 
Objectives: To determine the frequency of CR-BSI (catheter- 
related bloodstream infection), causative microorganisms and 
resistance pattern in cases with hemodialysis catheters in our depart- 
ment. 
Methods: From March 1997 to March 1998, 67 hemodialysis 
patients (37 male, 30 female; mean age 52 years; range 17-84) were 
evaluated. The CDC criteria were used to diagnose the CR-BSI. 
The tips of catheters were cultured by Maki's method. At the same 
time, two different blood cultures, one from peripheral vein, and the 
other through the catheter lumen, were drawn. Swab cultures from 
the catheter exit sites were also performed. The isolation and iden- 
tification of bacteria was performed by conventional methods and the 
susceptibility testing by the Bauer-Kirby method. 
Results: The exit site infecaon, CR-BSI and colonization were 
found in 14 (20%) patients, 17 (25%) patients and 3 (4%) patients, 
respectively The etiologic agents in CR-BSI were as follows: coag- 
ulase-negative staphylococci (8), Staphylococcus aureus (5). Enterobacter 
sp. (l), E. coli (I), Acinetobacter sp. ( 1 )  and Profeeus sp. (1). MRCNS 
and MRSA were found in proportions of 42% and 83%. 
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Conclusions: The majority of hemodialysis CR-BSl was due to 
staphylococci (76%). Methicillin resistance was extremely prevalent 
(MRSA 83% and MKCNS 42%). These results suggest that preven- 
tive measures for CK-BSI and :ippropriate anti-staphylococcal antibi- 
otic therapy are necessary in our  department. 
(p11071 imipenemlciiastin treatment in CAPD 
peritonitis 
A. Kapuagasi, C. Agalar, M. D'uranay, A. Elaldi, Y. Gurbdz, R. 
Turkyilniaz. Sn/cyuion Drmiref Ckiiversify, Isparta, Titrkry 
Objectives: In this open, non-randomized trial, the efficacy of 
inlipenem/cilastin (IMP) was investigated in 88 peritonitis episodes 
in SO chronic renal failure patients with continuous ainbulatory peri- 
toneal dialysis (CAPD) over a period of 1 year. 
Methods: Microbiological confirination was done in 77% of these 
episodes. Biphasic Castenada and blood agar McConkey media were 
used for microbiological determination. lmipenem was used as the 
empirical therapy in all patients. A I-g loading dose of IMP IV was 
given to all patients on the first day. 100 nig IMP in 2 L dialysate 
solution was administered to all patients as the standard therapy for 
the following 9 days. Primary response was considered to occur when 
PMNL tiumber in the dialysate decreased to 100/niL.. 
Results: The  blood culture system (77%) was found to be more 
sensitive than the plaque method (43%) in isolating the microorgan- 
isms, which were as follows in order of decreasing frequency: 
Staphylococtrrs epidwmidir (SO'%), E. co/i (17%), Staphy/ococcrts aurrus 
(13%)) and K/cbsie/la spp. (7%). The  primary response ratc to 
iinipeneni treatment was 93% Relapse was found in 4% of casts 
within 14 days after the end of therapy. The  overall cure rate was 
89% 
Conclusions: The finding of this study indicate that IMP treat- 
ment is highly efficient in CAPD peritonitis. 
Ip11081 Ventricular-peritoneal shunt infection in 
neurosurgical patients: a 10-year experience 
J. Martinez-Lacasa, E Vila, J. Tsst, J.M. Tricas, A. Aparicio, E. 
Cuchi, M. Marqucz, J. Garau. Hospital Mutua de Terrassa, Errasso, 
Spairr 
Our  aim Wac to determine the incidence, clinical characteristics, 
microbioloby and treatment of shunt infection in our hospital. 
All episode$ ofchunt infection from 1988 to 1998 were reviewed. 
We analyze baseline characteristics. oiitcoine and efficacy of medical 
and surgical therapy. 
Lhring this period a total of 220 shunts were inserted and 24 
patieiits/?h epi5odt.s of infection occurred. 24 shunts were ventricu- 
lar-peritoneal and 2 were luinboperitoneal. All patients had received 
prophylaxis with systemic vanconiycin. 
Among the 26 episodes ofshunt infection there were 8 female and 
16 male with n mean age of 64 years (range: 19-84). The mean lag 
time to infection wac 493 days (range: 5-2190). The  overall incidence 
rate of shunt infection was 11.8%. Twelve (46%) epirodes occurred 
before 2 months of shunt placement (early infection), whereas the 
remainins 14 (54%)) were cotisitlered to be late infectious (more than 
6 ~noiiths). There was no niortdity due to shunt infection. 
Sra~~hyloceccrrs epidermidis was the most frequently isolated pathogrn 
(73%), followed by S. airreus (ll%), Prepionibacterirrm aoies (7.6%1), 
C e m e h  mor/ii//orutn (3.8%) an Streptococcris viridanr (3%). All patients 
received antibiotic therapy (22 only systemic, 4 systemic and intra- 
ventricular); 20/26 patients had two-stage shunt replacement, and the 
rest had one-stage surgery. 2 / 0  of one-stage replaceinent patlents 
devcloped a second episode of shunt infection. Cure was achieved in 
all patients. 
Conclusions: We have a moderate-high incidence ofshunt itifec- 
tion. Staphylococms epidermidir is the most important pathogen. 
Prophylaxis with systemic vancornycin does not appear to be usefill 
in prevention of Gram-po\itive infection. In our opinion, treatment 
with antibiotics and two-stage replacement surgery probably con\& 
tute tht  best option. Intraventricular vanconiycin is a potentnlly 
useful prophylaxis arid prospective studies are warranted. 
(p11091 In vitro activity of fosfomycin (F) in 
combination with vancomycin (V) or 
teicoplanin (T) against Staphylococcus aureus 
isolated from device-associated infections 
unresponsive to glycopeptide therapy 
A. Tarasi, I? Baiocchi, A. Capone, D. Tarasi, C .  Brmdimarte, 
M. Venditti. Deparfnrent of C/irricu/ Medirine, U ~ r i r ~ v i t 2  di  Rorrrn La 
Sapicnza, Roriie, Italy 
Objectives: Srap/iy/ocorcrts artreus (SA) device-associated infections 
(DAI), mainly caused by niethicillin-resi\tant (MR) strains, represent 
an actual problem in inany ltalian hospitals. Wide use ofglycopep- 
tides has led to decreased susceptibility to T and V among SA recov- 
ered from hospitalized patients. We recently collected some strains 
with decreased susceptibility to T (MIC range: 2-8 mg/L) and V 
(MIC range: 2-4 ing/L) isolated froin well-docurnented infectious 
unresponsive to or relapsing after G therapy despite device reriioval. 
SA strains with such antimicrobial susceptibility patterns havr never 
been isolated before in our hospital, and nor had we received .my of 
them from other institutions located in Rome. Fo\fomycin i\ a inole- 
cule that inhibits the early stage of peptoglycan synthesis and \bows 
broad-spectrum bactericidal activity against Gram-positive and 
Gram-negative bacteria, and has synergistic activity with the inajor- 
ity of dntirnicrobial agents. 
Methods: We tested the in vitro bactericidal activity of F alone 
and in combination with V or T at diffei-ent mult1pler of MI(; against 
7 niethicillin-resistant S. airreus (MIISA), using a killing-curve 
method. 
Results: MICs of V ranged from 1 to 4 mg/L, MlCs of T rangcd 
from 2 t o  8 mg/L, and MlCs of F were 8 mg/L for two strain%. .ind 
128 mg/L for the remaining strains. The  7 strains were tolerant when 
tested for V or T used alone at 2XMIC F at 2XMIC WAS bacteri- 
cidal (reduction of 2 log of the inoculuin) only against the two 
susceptible strains. In all case\ the combination appeared to be bacte- 
ricidal a t  MlC for V and T plus a concentration of 8 mg/L for F. 
When compared with V plus F, T plus F showed a faster bactrrici- 
dal effcct (reduction of 1 more log a h  6 ti). Both coinbiiiations 
showed a much higher bactericidal effect (reduction of 4 log) in  the 
case of the 2 F-susceptible strains. 
Conclusions: If these results are sonfirined in vivo by animal 
experiments, the combination of F with G might be useful for treat- 
ing device-associated infections, and in preventing the worrying 
phenomenon of the MIC increasing for glycopeptides. 
